Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.35 |
| ▸ | CFTR | P13569 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.35 |
| ▸ | GRM2 | Q14416 | 4/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4461703 | 0.84 | KCNA5 (0.43) | KCNA5MAPTSMN1; SMN2LMNAL3MBTL1 | |
| SCHEMBL4459578 | 0.79 | KCNA5 (0.43) | KCNA5MAPTSMN1; SMN2LMNAL3MBTL1 | |
| SCHEMBL4458827 | 0.77 | CYP19A1 (0.43) | KCNA5MAPTSMN1; SMN2LMNAL3MBTL1 | |
| SCHEMBL13971458 | 0.75 | ELOVL1 (0.42) | KCNA5MAPTSMN1; SMN2LMNAL3MBTL1 | |
| SCHEMBL4460589 | 0.74 | CYP19A1 (0.46) | KCNA5MAPTSLC6A2SLC6A4 | |
| SCHEMBL4457212 | 0.73 | KCNA5 (0.42) | KCNA5SLC6A2SLC6A4CFTRSLC6A3 | |
| SCHEMBL4456909 | 0.72 | CYP19A1 (0.38) | KCNA5MAPT | |
| SCHEMBL4461911 | 0.72 | CYP19A1 (0.46) | KCNA5MAPTLMNASLC6A2SLC6A4 | |
| SCHEMBL4459300 | 0.71 | KCNA5 (0.36) | KCNA5MAPTSMN1; SMN2LMNAL3MBTL1 | |
| SCHEMBL4453034 | 0.71 | KCNA5 (0.33) | KCNA5MAPTSMN1; SMN2LMNAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090030043-A1 | Potassium Channel Inhibitors | MERCK SHARP & DOHME CORP. | 2009-01-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090030043-A1 | Potassium Channel Inhibitors | KCNJ2, KCNH2, KCNH3 | KCNA5 11/4885MAPT 2245/4885SMN1; SMN2 3817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.